Venture
Amunix Pharmaceuticals, Inc.
Latest Form D 2021-03-09- CIK 1805035
- State CA
- Biotechnology
- 4 Form D offerings since 2020-03-12
- Total sold
- $201M
- across 4 offerings
- Rounds
- 4
- Form D offerings since 2020-03-12
- Latest round
- $117M
- 2021-03-09 · 021-391600
- Investors
- 28
- on the latest round
Connected
named in its Form D filingsOfferings · since 2020-03-124 Form D offeringsExemptions506(b)People · Item 3Angie You + 7 moreInvestors · dashboard2 inferred investors
Amunix Pharmaceuticals, Inc.CIK 1805035
Round timeline
amount sold · by first filed2021-03-09 · $117M
- 2020-03-12$83.6M021-362661
- 2020-07-17$0021-371303
- 2021-01-21$0021-386939
- 2021-03-09$117M021-391600
Hover a dot or row, or tab through the dots · bars scaled to the largest round ($117M)
Form D offerings
One line per offering, amendments folded in, newest first
| File | First filed | Latest | Sought | Sold | Investors | Exemptions |
|---|---|---|---|---|---|---|
| 021-391600 | First filed2021-03-09 | Latest2021-03-09 | Sought$117M | Sold$117M | Investors28 | Exemptions506(b) |
| 021-386939 | First filed2021-01-21 | Latest2021-01-21 | Sought$743K | Sold$0 | Investors1 | Exemptions506(b) |
| 021-371303 | First filed2020-07-17 | Latest2020-07-17 | Sought$2.6M | Sold$0 | Investors3 | Exemptions506(b) |
| 021-362661 | First filed2020-03-12 | Latest2020-03-12 | Sought$83.6M | Sold$83.6M | Investors21 | Exemptions506(b) |
Who backs Amunix Pharmaceuticals, Inc. — 2 inferred investors — and every Form D as filedSee plans
People
Named in Item 3 of its latest Form D, filed 2021-03-09
| Name | Relationship |
|---|---|
| Angie You | RelationshipExecutive Officer, Director |
| Volker Schellenberger | RelationshipExecutive Officer |
| James Brush | RelationshipDirector |
| Richard Heyman | RelationshipDirector |
| David Hirsch | RelationshipDirector |
| Otello Stampacchia | RelationshipDirector |
| James Topper | RelationshipDirector |
| Trisha Millican | RelationshipDirector |
Facts
As its latest Form D states them
- Industry
- Biotechnology
- State
- California (CA)
- Exemptions
- Rule 506(b)
- First filed
- 2020-03-12
- Latest filing
- 2021-03-09
Who backs Amunix Pharmaceuticals, Inc.
Form D names a startup's officers and directors, not its investors. The dashboard infers them — the venture funds whose own filings and people overlap this company's rounds — and lays every Form D and amendment it filed beside the totals above.
- Inferred investors — the funds and firms behind it, from co-filings and shared people
- Every Form D and amendment as filed, with what each one stated
- Its rounds in sequence: the gap between them and whether they grew
- Everyone its filings name, linked to their other companies, with its addresses and phone numbers
Part of the Venture plan — $140/mo at launch pricing ($350 list)
See plansExternal link: SEC Filings ↗